Cystinosis Global Clinical Trials Review, H2, 2015

1
Cystinosis Global Clinical Trials Review, H2, 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Cystinosis Global Clinical Trials Review, H2,
  2015 provides an overview of Cystinosis clinical
  trials scenario. This report provides top line
  data relating to the clinical trials on
  Cystinosis. Report includes an overview of trial
  numbers and their average enrollment in top
  countries conducted across the globe. The report
  offers coverage of disease clinical trials by
  region, country (G7 E7) , phase, trial status,
  end points status and sponsor type.
• Scope
• The report provides a snapshot of the global
  clinical trials landscape
• Report provides top level data related to the
  clinical trials by Region, Country (G7 E7) ,
  Trial Status, Trial Phase, Sponsor Type and End
  point status
• The report reviews top companies involved and
  enlists all trials (Trial title, Phase, and
  Status) pertaining to the company
• The report provides all the unaccomplished trials
  (Terminated, Suspended and Withdrawn) with reason
  for unaccomplishment
• The Report provides enrollment trends for the
  past five years
• Report provides latest news for the past three
  months
• Read More At http//www.researchbeam.com/cystin
  osis-global-clinical-trials-review-h2-2015-market

3


Table of Content
Table of Contents 2List of Tables 4List of
Figures 5Introduction 6Cystinosis 6Report
Guidance 6Clinical Trials by Region 7Clinical
Trials and Average Enrollment by Country 8Top
Five Countries Contributing to Clinical Trials in
Europe 10Top Countries Contributing to Clinical
Trials in North America 11Top Countries
Contributing to Clinical Trials in Central and
South America 12Clinical Trials by G7 Countries
Proportion of Cystinosis to Genetic Disorders
Clinical Trials 13Clinical Trials by Phase in G7
Countries 14Clinical Trials in G7 Countries by
Trial Status 15Clinical Trials by E7 Countries
Proportion of Cystinosis to Genetic Disorders
Clinical Trials 16Clinical Trials by Phase 17In
Progress Trials by Phase 18Clinical Trials by
Trial Status 19Clinical Trials by End Point
Status 20Subjects Recruited Over a Period of
Time 21Clinical Trials by Sponsor Type
22Prominent Sponsors 23Top Companies
Participating in Cystinosis Therapeutics Clinical
Trials 24
4


Table of Content
Prominent Drugs 25Clinical Trial Profiles
26Clinical Trial Overview of Top Companies
26Raptor Pharmaceuticals Corp. 26Clinical Trial
Overview of Raptor Pharmaceuticals Corp.
26Sigma-Tau S.p.A. 27Clinical Trial Overview of
Sigma-Tau S.p.A. 27ICON Plc 28Clinical Trial
Overview of ICON Plc 28Clinical Trial Overview
of Top Institutes / Government 29National Eye
Institute 29Clinical Trial Overview of National
Eye Institute 29National Human Genome Research
Institute 30Clinical Trial Overview of National
Human Genome Research Institute 30FDA Office of
Orphan Products Development 31Clinical Trial
Overview of FDA Office of Orphan Products
Development 31Hospices Civils de Lyon
32Clinical Trial Overview of Hospices Civils de
Lyon 32Hospital Universitari Vall d'Hebron
33 Enquire At http//www.researchbeam.com/cysti
nosis-global-clinical-trials-review-h2-2015-market
/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/cystinosis-global-clin
ical-trials-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com